Hepatitis Therapeutics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Hepatitis Therapeutics Market to 2027 - Global Analysis and Forecasts By Disease Type (Hepatitis A, Hepatitis B, Hepatitis C, Others); Product (Hepatitis B Vaccine, Anti-Viral Drugs); Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

Report Code: TIPRE00003488 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Hepatitis is the inflammation of the liver caused due to a viral infection. Hepatitis is among the major reason for health care burden in developed as well as developing countries. Patients with autoimmune disorder are adding to rise in the prevalence of hepatitis. Elderly population and varying societal behavior adding to this sturdy growth. Rising viral infection including type A, B, C, D, E and possible G are major cause of hepatitis. Hepatitis B and C can cause chronic hepatitis. Some of the symptoms of acute hepatitis A consists of fatigue, flu like conditions or dark urine however chronic hepatitis are mild and non-specific.

MARKET DYNAMICS
The hepatitis therapeutics market is anticipated to grow in the forecast period owing to driving factors such as increasing number of hepatitis infected population, rising consumption of alcohol & drugs, and successful and better accessibility to hepatitis drugs. However, the access to treatments of the disease has been limited to people who have a high income level owing to high drug price that hampers the sales of hepatitis therapeutics and eventually is expected to hinder the market growth.

MARKET SCOPE
The "Global Hepatitis Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of hepatitis therapeutics market with detailed market segmentation by disease type, product, and distribution channel, and geography. The global hepatitis therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading hepatitis therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global hepatitis therapeutics market is segmented on the basis disease type, product and distribution channel. Based on disease type, the market is segmented as hepatitis A, hepatitis B, hepatitis C, and others. The hepatitis therapeutics market, based on product is segmented into hepatitis B vaccine and anti-viral drugs. By distribution channel the hepatitis therapeutics market is segmented into hospital pharmacies, retail pharmacies and online pharmacies.


REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hepatitis therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hepatitis therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting hepatitis therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hepatitis therapeutics market in these regions.

MARKET PLAYERS
The reports cover key developments in the hepatitis therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Hepatitis Therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for hepatitis therapeutics market in the global market. Below mentioned is the list of few companies engaged in the hepatitis therapeutics market.

The report also includes the profiles of key hepatitis therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Gilead
  • Johnson and Johnson
  • Bristol Myers Squibb Company
  • Merck & Co., Inc.
  • AbbVie Inc.
  • F Hoffmann-La Roche Ltd.
  • LAURUS Labs
  • Zydus Cadila
  • Cipla Inc.
  • Hetero Healthcare Limited
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.


TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Hepatitis Therapeutics Market - By Disease Type
1.3.2 Hepatitis Therapeutics Market - By Product
1.3.3 Hepatitis Therapeutics Market - By Distribution Channel
1.3.4 Hepatitis Therapeutics Market - By Region
1.3.4.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. HEPATITIS THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. HEPATITIS THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. HEPATITIS THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. HEPATITIS THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. HEPATITIS THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. HEPATITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE TYPE
7.1. OVERVIEW
7.2. DISEASE TYPE MARKET FORECASTS AND ANALYSIS
7.3. HEPATITIS A
7.3.1. Overview
7.3.2. Hepatitis A Market Forecast and Analysis
7.4. HEPATITIS B
7.4.1. Overview
7.4.2. Hepatitis B Market Forecast and Analysis
7.5. HEPATITIS C
7.5.1. Overview
7.5.2. Hepatitis C Market Forecast and Analysis
7.6. OTHERS
7.6.1. Overview
7.6.2. Others Market Forecast and Analysis

8. HEPATITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
8.1. OVERVIEW
8.2. PRODUCT MARKET FORECASTS AND ANALYSIS
8.3. HEPATITIS B VACCINE
8.3.1. Overview
8.3.2. Hepatitis B Vaccine Market Forecast and Analysis
8.4. ANTI-VIRAL DRUGS
8.4.1. Overview
8.4.2. Anti-Viral Drugs Market Forecast and Analysis

9. HEPATITIS THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACIES
9.3.1. Overview
9.3.2. Hospital Pharmacies Market Forecast and Analysis
9.4. RETAIL PHARMACIES
9.4.1. Overview
9.4.2. Retail Pharmacies Market Forecast and Analysis
9.5. ONLINE PHARMACIES
9.5.1. Overview
9.5.2. Online Pharmacies Market Forecast and Analysis

10. HEPATITIS THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Hepatitis Therapeutics Market Overview
10.1.2 North America Hepatitis Therapeutics Market Forecasts and Analysis
10.1.3 North America Hepatitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.1.4 North America Hepatitis Therapeutics Market Forecasts and Analysis - By Product
10.1.5 North America Hepatitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Hepatitis Therapeutics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Hepatitis Therapeutics Market
10.1.6.1.1 United States Hepatitis Therapeutics Market by Disease Type
10.1.6.1.2 United States Hepatitis Therapeutics Market by Product
10.1.6.1.3 United States Hepatitis Therapeutics Market by Distribution Channel
10.1.6.2 Canada Hepatitis Therapeutics Market
10.1.6.2.1 Canada Hepatitis Therapeutics Market by Disease Type
10.1.6.2.2 Canada Hepatitis Therapeutics Market by Product
10.1.6.2.3 Canada Hepatitis Therapeutics Market by Distribution Channel
10.1.6.3 Mexico Hepatitis Therapeutics Market
10.1.6.3.1 Mexico Hepatitis Therapeutics Market by Disease Type
10.1.6.3.2 Mexico Hepatitis Therapeutics Market by Product
10.1.6.3.3 Mexico Hepatitis Therapeutics Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Hepatitis Therapeutics Market Overview
10.2.2 Europe Hepatitis Therapeutics Market Forecasts and Analysis
10.2.3 Europe Hepatitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.2.4 Europe Hepatitis Therapeutics Market Forecasts and Analysis - By Product
10.2.5 Europe Hepatitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Hepatitis Therapeutics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Hepatitis Therapeutics Market
10.2.6.1.1 Germany Hepatitis Therapeutics Market by Disease Type
10.2.6.1.2 Germany Hepatitis Therapeutics Market by Product
10.2.6.1.3 Germany Hepatitis Therapeutics Market by Distribution Channel
10.2.6.2 France Hepatitis Therapeutics Market
10.2.6.2.1 France Hepatitis Therapeutics Market by Disease Type
10.2.6.2.2 France Hepatitis Therapeutics Market by Product
10.2.6.2.3 France Hepatitis Therapeutics Market by Distribution Channel
10.2.6.3 Italy Hepatitis Therapeutics Market
10.2.6.3.1 Italy Hepatitis Therapeutics Market by Disease Type
10.2.6.3.2 Italy Hepatitis Therapeutics Market by Product
10.2.6.3.3 Italy Hepatitis Therapeutics Market by Distribution Channel
10.2.6.4 Spain Hepatitis Therapeutics Market
10.2.6.4.1 Spain Hepatitis Therapeutics Market by Disease Type
10.2.6.4.2 Spain Hepatitis Therapeutics Market by Product
10.2.6.4.3 Spain Hepatitis Therapeutics Market by Distribution Channel
10.2.6.5 United Kingdom Hepatitis Therapeutics Market
10.2.6.5.1 United Kingdom Hepatitis Therapeutics Market by Disease Type
10.2.6.5.2 United Kingdom Hepatitis Therapeutics Market by Product
10.2.6.5.3 United Kingdom Hepatitis Therapeutics Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Hepatitis Therapeutics Market Overview
10.3.2 Asia-Pacific Hepatitis Therapeutics Market Forecasts and Analysis
10.3.3 Asia-Pacific Hepatitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.3.4 Asia-Pacific Hepatitis Therapeutics Market Forecasts and Analysis - By Product
10.3.5 Asia-Pacific Hepatitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Hepatitis Therapeutics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Hepatitis Therapeutics Market
10.3.6.1.1 Australia Hepatitis Therapeutics Market by Disease Type
10.3.6.1.2 Australia Hepatitis Therapeutics Market by Product
10.3.6.1.3 Australia Hepatitis Therapeutics Market by Distribution Channel
10.3.6.2 China Hepatitis Therapeutics Market
10.3.6.2.1 China Hepatitis Therapeutics Market by Disease Type
10.3.6.2.2 China Hepatitis Therapeutics Market by Product
10.3.6.2.3 China Hepatitis Therapeutics Market by Distribution Channel
10.3.6.3 India Hepatitis Therapeutics Market
10.3.6.3.1 India Hepatitis Therapeutics Market by Disease Type
10.3.6.3.2 India Hepatitis Therapeutics Market by Product
10.3.6.3.3 India Hepatitis Therapeutics Market by Distribution Channel
10.3.6.4 Japan Hepatitis Therapeutics Market
10.3.6.4.1 Japan Hepatitis Therapeutics Market by Disease Type
10.3.6.4.2 Japan Hepatitis Therapeutics Market by Product
10.3.6.4.3 Japan Hepatitis Therapeutics Market by Distribution Channel
10.3.6.5 South Korea Hepatitis Therapeutics Market
10.3.6.5.1 South Korea Hepatitis Therapeutics Market by Disease Type
10.3.6.5.2 South Korea Hepatitis Therapeutics Market by Product
10.3.6.5.3 South Korea Hepatitis Therapeutics Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Hepatitis Therapeutics Market Overview
10.4.2 Middle East and Africa Hepatitis Therapeutics Market Forecasts and Analysis
10.4.3 Middle East and Africa Hepatitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.4.4 Middle East and Africa Hepatitis Therapeutics Market Forecasts and Analysis - By Product
10.4.5 Middle East and Africa Hepatitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Hepatitis Therapeutics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Hepatitis Therapeutics Market
10.4.6.1.1 South Africa Hepatitis Therapeutics Market by Disease Type
10.4.6.1.2 South Africa Hepatitis Therapeutics Market by Product
10.4.6.1.3 South Africa Hepatitis Therapeutics Market by Distribution Channel
10.4.6.2 Saudi Arabia Hepatitis Therapeutics Market
10.4.6.2.1 Saudi Arabia Hepatitis Therapeutics Market by Disease Type
10.4.6.2.2 Saudi Arabia Hepatitis Therapeutics Market by Product
10.4.6.2.3 Saudi Arabia Hepatitis Therapeutics Market by Distribution Channel
10.4.6.3 U.A.E Hepatitis Therapeutics Market
10.4.6.3.1 U.A.E Hepatitis Therapeutics Market by Disease Type
10.4.6.3.2 U.A.E Hepatitis Therapeutics Market by Product
10.4.6.3.3 U.A.E Hepatitis Therapeutics Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Hepatitis Therapeutics Market Overview
10.5.2 South and Central America Hepatitis Therapeutics Market Forecasts and Analysis
10.5.3 South and Central America Hepatitis Therapeutics Market Forecasts and Analysis - By Disease Type
10.5.4 South and Central America Hepatitis Therapeutics Market Forecasts and Analysis - By Product
10.5.5 South and Central America Hepatitis Therapeutics Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Hepatitis Therapeutics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Hepatitis Therapeutics Market
10.5.6.1.1 Brazil Hepatitis Therapeutics Market by Disease Type
10.5.6.1.2 Brazil Hepatitis Therapeutics Market by Product
10.5.6.1.3 Brazil Hepatitis Therapeutics Market by Distribution Channel
10.5.6.2 Argentina Hepatitis Therapeutics Market
10.5.6.2.1 Argentina Hepatitis Therapeutics Market by Disease Type
10.5.6.2.2 Argentina Hepatitis Therapeutics Market by Product
10.5.6.2.3 Argentina Hepatitis Therapeutics Market by Distribution Channel

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. HEPATITIS THERAPEUTICS MARKET, KEY COMPANY PROFILES
12.1. GILEAD
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. JOHNSON & JOHNSON
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BRISTOL MYERS SQUIBB COMPANY
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. MERCK & CO., INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. ABBVIE INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCHE LTD.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. LAURUS LABS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ZYDUS CADILA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. CIPLA INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. HETERO HEALTHCARE LIMITED
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Gilead
2. Johnson and Johnson
3. Bristol Myers Squibb Company
4. Merck & Co., Inc.
5. AbbVie Inc.
6. F Hoffmann-La Roche Ltd.
7. LAURUS Labs
8. Zydus Cadila
9. Cipla Inc.
10. Hetero Healthcare Limited